These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30708194)

  • 1. IL-21-mediated expansion of Vγ9Vδ2 T cells is limited by the Tim-3 pathway.
    Wu K; Zhao H; Xiu Y; Li Z; Zhao J; Xie S; Zeng H; Zhang H; Yu L; Xu B
    Int Immunopharmacol; 2019 Apr; 69():136-142. PubMed ID: 30708194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.
    Thedrez A; Harly C; Morice A; Salot S; Bonneville M; Scotet E
    J Immunol; 2009 Mar; 182(6):3423-31. PubMed ID: 19265120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-18 activates Vγ9Vδ2
    Murday AS; Chaudhry S; Pauza CD
    Immunology; 2017 Aug; 151(4):385-394. PubMed ID: 28342224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
    Gertner-Dardenne J; Castellano R; Mamessier E; Garbit S; Kochbati E; Etienne A; Charbonnier A; Collette Y; Vey N; Olive D
    J Immunol; 2012 May; 188(9):4701-8. PubMed ID: 22467661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tim-3 suppresses the killing effect of Vγ9Vδ2 T cells on colon cancer cells by reducing perforin and granzyme B expression.
    Li X; Lu H; Gu Y; Zhang X; Zhang G; Shi T; Chen W
    Exp Cell Res; 2020 Jan; 386(1):111719. PubMed ID: 31726050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scrutinizing the Expression and Blockade of Inhibitory Molecules Expressed on T Cells from Acute Myeloid Leukemia Patients.
    Abdolmaleki M; Mojtabavi N; Zavvar M; Vaezi M; Noorbakhsh F; Nicknam MH
    Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):265-273. PubMed ID: 29908544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vδ2 T cell subsets, defined by PD-1 and TIM-3 expression, present varied cytokine responses in acute myeloid leukemia patients.
    Wu K; Feng J; Xiu Y; Li Z; Lin Z; Zhao H; Zeng H; Xia W; Yu L; Xu B
    Int Immunopharmacol; 2020 Mar; 80():106122. PubMed ID: 31955066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-mediated activation of human ex vivo-expanded Vγ9Vδ2 T cells.
    Domae E; Hirai Y; Ikeo T; Goda S; Shimizu Y
    Oncotarget; 2017 Jul; 8(28):45928-45942. PubMed ID: 28521284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive analysis of primary acute myeloid leukemia identifies biomarkers predicting susceptibility to human allogeneic Vγ9Vδ2 T cells.
    Gundermann S; Klinker E; Kimmel B; Flierl U; Wilhelm M; Einsele H; Kunzmann V
    J Immunother; 2014; 37(6):321-30. PubMed ID: 24911793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer.
    Heon EK; Wulan H; Macdonald LP; Malek AO; Braunstein GH; Eaves CG; Schattner MD; Allen PM; Alexander MO; Hawkins CA; McGovern DW; Freeman RL; Amir EP; Huse JD; Zaltzman JS; Kauff NP; Meyers PG; Gleason MH; Overholtzer MG; Wiseman SS; Streutker CD; Asa SW; McAlindon TP; Newcomb PO; Sorensen PM; Press OA
    Biochem Biophys Res Commun; 2015 Aug; 464(1):360-6. PubMed ID: 26141233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain.
    Izumi T; Kondo M; Takahashi T; Fujieda N; Kondo A; Tamura N; Murakawa T; Nakajima J; Matsushita H; Kakimi K
    Cytotherapy; 2013 Apr; 15(4):481-91. PubMed ID: 23391461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
    Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
    Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functional potency of natural killer cells in response to IL-2/IL-15/IL-21 stimulation is limited by a concurrent upregulation of Tim-3 in bladder cancer.
    Zhang W; Feng H; Chen Q; Lu X; Ge J
    Exp Cell Res; 2018 Nov; 372(2):92-98. PubMed ID: 30243902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells.
    Xiao L; Chen C; Li Z; Zhu S; Tay JC; Zhang X; Zha S; Zeng J; Tan WK; Liu X; Chng WJ; Wang S
    Cytotherapy; 2018 Mar; 20(3):420-435. PubMed ID: 29402645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation by cytokines (IL-12, IL-15, IL-4 and IL-10) of the Vgamma9Vdelta2 T cell response to mycobacterial phosphoantigens in responder and anergic HIV-infected persons.
    Boullier S; Poquet Y; Debord T; Fournie JJ; Gougeon ML
    Eur J Immunol; 1999 Jan; 29(1):90-9. PubMed ID: 9933090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Density Lipoprotein Uptake Inhibits the Activation and Antitumor Functions of Human Vγ9Vδ2 T Cells.
    Rodrigues NV; Correia DV; Mensurado S; Nóbrega-Pereira S; deBarros A; Kyle-Cezar F; Tutt A; Hayday AC; Norell H; Silva-Santos B; Dias S
    Cancer Immunol Res; 2018 Apr; 6(4):448-457. PubMed ID: 29358174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-independent induction of Tim-3 expression on human T cells by the common γ-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway.
    Mujib S; Jones RB; Lo C; Aidarus N; Clayton K; Sakhdari A; Benko E; Kovacs C; Ostrowski MA
    J Immunol; 2012 Apr; 188(8):3745-56. PubMed ID: 22422881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemia.
    Le Floch AC; Orlanducci F; Béné MC; Ben Amara A; Rouviere MS; Salem N; Le Roy A; Cordier C; Demerlé C; Granjeaud S; Hamel JF; Ifrah N; Cornillet-Lefebvre P; Delaunay J; Récher C; Delabesse E; Pigneux A; Vey N; Chretien AS; Olive D
    Blood Adv; 2024 Aug; 8(16):4262-4275. PubMed ID: 38788176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1
    Batorov EV; Ineshina AD; Aristova TA; Denisova VV; Sizikova SA; Batorova DS; Ushakova GY; Shevela EY; Chernykh ER
    Oncol Res; 2024; 32(10):1575-1587. PubMed ID: 39308517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-23R and TCR signaling drives the generation of neonatal Vgamma9Vdelta2 T cells expressing high levels of cytotoxic mediators and producing IFN-gamma and IL-17.
    Moens E; Brouwer M; Dimova T; Goldman M; Willems F; Vermijlen D
    J Leukoc Biol; 2011 May; 89(5):743-52. PubMed ID: 21330350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.